1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors
摘要:
A novel series of 1-aryl-3,4-dihydro-1H-quinolin-2-ones have been discovered as potent and selective norepinephrine reuptake inhibitors. Efficient synthetic routes have been developed which allow for the multi-gram preparation of both final targets and advanced intermediates for SAR expansion. (c) 2005 Elsevier Ltd. All rights reserved.
1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors
摘要:
A novel series of 1-aryl-3,4-dihydro-1H-quinolin-2-ones have been discovered as potent and selective norepinephrine reuptake inhibitors. Efficient synthetic routes have been developed which allow for the multi-gram preparation of both final targets and advanced intermediates for SAR expansion. (c) 2005 Elsevier Ltd. All rights reserved.
This invention relates to compounds of formula (I)
where —X—, n, R
1
, R
3
and Ar— have the values defined herein, their preparation, and use as pharmaceuticals.
3,4-DIHYDRO-1H-QUINOLIN-2-ONE DERIVATIVES AS NOREPINEPHRINE REUPTAKE INHIBITORS
申请人:ELI LILLY AND COMPANY
公开号:EP1622874B1
公开(公告)日:2007-10-03
Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors
申请人:Allen John Albert
公开号:US20060241188A1
公开(公告)日:2006-10-26
Provided are methods and medicaments for treating a Pervasive Developmental Disorder, comprising administering to a patient in need of such treatment an effective amount of a selective norepinephrine reuptake inhibitor.
Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
申请人:Allen John Albert
公开号:US20070015786A1
公开(公告)日:2007-01-18
Selective norepinephrine reuptake inhibitors are useful for the prevention or treatment of hot flashes, vasomotor symptoms, impulse control disorders or personality change due to a general medical condition.
Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors
申请人:Kelsey Kenneth Douglas
公开号:US20070032554A1
公开(公告)日:2007-02-08
Provided are methods and medicaments for treating stuttering or another communication disorder, comprising administering to a patient in need of such treatment an effective amount of a selective norepinephrine reuptake inhibitor.